Quick Takeaways
- BlackRock Portfolio Management LLC filed SCHEDULE 13G for Vanda Pharmaceuticals Inc. Common Stock (VNDA).
- Disclosed ownership: 7.7%.
- Date of event: 31 Mar 2025.
BlackRock Portfolio Management LLC - 31 Mar 2025 SCHEDULE 13G Report for Vanda Pharmaceuticals Inc. Common Stock (VNDA)
- Filing Manager
- BlackRock Portfolio Management LLC
- Reporting Manager
- BlackRock Portfolio Management LLC
- Symbol
- VNDA
- Shares outstanding
- 58,169,948 shares
- Disclosed Ownership
- 4,479,086 shares
- Ownership
- 7.7%
- Form type
- SCHEDULE 13G
- Filing time
- 15 Apr 2025, 17:04:29 UTC
- Date of event
- 31 Mar 2025
- Next filing
- 21 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"BlackRock Portfolio Management LLC disclosed 7.7% ownership in Vanda Pharmaceuticals Inc. Common Stock (VNDA) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 15 Apr 2025, 17:04.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC | 7.7% | 4,479,086 | 3,625,295 | 0 | Spencer Fleming | Managing Director |